P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA...

por Atallah, Ehab, Mauro, Michael, Sasaki, Koji, Yair Levy, Moshe, Koller, Paul, Sadek, Islam, Yang, Daisy, Ruckel-Kumar, Julie, Khan, Mahmudul, Cortes, Jorge
Publicado 2023